Similar Articles

• PS1-29: Preparing for Genetics Research on Serious Skin Rash in the HMO Research Network

  Cynthia Nakasato, Mark Schmidt, Aileen Uchida, Tracy Thomas, Mia Hemmes and Robert Davis

  • Clinical Medicine & Research November 2011, 9 (3-4) 179.3;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-29
• PS1-11: Feasibility of Prospective Surveillance for Adverse Drug Events – Lessons Learned from a 12-Month Pilot Study

  Sascha Dublin, Taliser Avery, Craig Cheetham, Robert Davis, Martin Kulldorff, Lingling Li, Liyan Liu and Jeffrey Brown

  • Clinical Medicine & Research November 2011, 9 (3-4) 181.2;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-11
• PS1-31: Assessing the Potential for Research on Genetics of Drug Induced Liver Injury in the HMORN

  Pamala Pawloski, Brita Hedblom, Paul Hitz, Brian Owens, Chris Anderson, Catherine McCarty, Steven Yale, Robert Davis, Mia Hemmes and John Schmelzer

  • Clinical Medicine & Research November 2011, 9 (3-4) 180.2;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-31
• PS1-5: The HMO Cancer Research Network: Evolution and Current Organization and Activities

  Lawrence Kushi, Heather Clancy and V. Paul Doria-Rose

  • Clinical Medicine & Research September 2013, 11 (3) 125.2;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.ps1-5
• C-B1-04: Piloting Use of the HMO Research Network Virtual Data Warehouse for Pelvic Inflammatory Disease Surveillance and Research

  Delia Scholes, Marsha Raebel, Onchee Yu, Jane Grafton, Hillard Weinstock and Catherine Satterwhite

  • Clinical Medicine & Research November 2011, 9 (3-4) 182.2;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-b1-04
• Tamoxifen-Induced Venothromboembolic Events: Exploring Validation of Putative Genetic Association

  Ingrid Glurich, Po-Huang Chyou, Jessica M. Engel, Deanna S. Cross and Adedayo A. Onitilo

  • Clinical Medicine & Research February 2013, 11 (1) 16;
  • DOI: https://doi.org/10.3121/cmr.2012.1101
• B3-4: Identification of Adverse Drug Events Post-Hospital Discharge in a Geriatric Population

  Jennifer Donovan, Abir Kanaan, Jennifer Tjia, Terry Field, Shawn Gagne, Lawrence Garber, Sarah Cutrona, Leslie Harrold, Peggy Preusse, George Reed and Jerry Gurwitz

  • Clinical Medicine & Research September 2013, 11 (3) 169.1;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.b3-4
• PS1-15: What has the HMO Research Network Done for You, Lately? How the Network is Responding to Investigators’ Needs

  Ella E Thompson, Sarah M Greene and Eric B Larson

  • Clinical Medicine & Research March 2010, 8 (1) 46.1;
  • DOI: https://doi.org/10.3121/cmr.8.1.46
• PS1-30: O Say Can You C(ER) – An Inventory of Comparative Effectiveness Research Capacity in the HMO Research Network

  Ella Thompson, Sarah Greene and Eric Larson

  • Clinical Medicine & Research December 2010, 8 (3-4) 208.1;
  • DOI: https://doi.org/10.3121/cmr.2010.943.ps1-30
• PS2-09: The HMO Research Network: Growth, Governance and Administrative Gaps

  Ella Thompson, Eric Larson, Sarah Greene and John Steiner

  • Clinical Medicine & Research August 2012, 10 (3) 174.2;
  • DOI: https://doi.org/10.3121/cmr.2012.1100.ps2-09

Previous

Next

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• 194